Submitted by Anonymous (not verified) on 20 October 2026 - 10:12
Human medicines European public assessment report (EPAR): Arikayce liposomal, amikacin, Date of authorisation: 27/10/2020, Revision: 6, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Arikayce liposomal, amikacin, Date of authorisation: 27/10/2020, Revision: 6, Status: Authorised